USPTO serial 79417277
LICIT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 30, 2026
- Examiner
- BLAKESLEE, RICHARD A
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LICIT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
LEIGH ANN LINDQUIST
LEIGH ANN LINDQUIST SUGHRUE MION PLLC2000 PENNSYLVANIA AVE. N.W., SUITE 9000WASHINGTON, DC 20006UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemical substances, chemical materials and chemical preparations for industrial purposes, commercial purposes, scientific purposes, non-medical biological purposes, non-medical biochemical purposes and non-medical biotechnological purposes, laboratory purposes and for use in manufacturing for the food industry, cosmetics industry, wood industry, textile industry, pharmaceutical industry and chemical industry; chemical preservatives for organic and inorganic materials and compositions, in particular for food, cosmetics and pharmaceuticals; coating compositions in the nature of chemicals, other than paint, namely, chemical agents for impregnating, binding and coating of textiles, furs and leather ; preservatives, in particular fixatives, for biological, biochemical, medical, dental, veterinary and pharmaceutical use; none of the aforesaid goods for use on batteries or anodes | ACTIVE | — |
| 003 | Washing and cleaning preparations, not for personal use and not for the body | ACTIVE | — |
| 005 | Medical, and pharmaceutical preparations for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination and immunostimmulation; dental preparations for disclosing plaque, removing plaque, anti-cavity dental coating, dental filling, dental casting, denture bonding and for the treatment and prevention of inflammations in the mouth and jaw area; veterinary pharmaceutical preparations for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination and immunostimmulation; chemical preparations for medical, dental, veterinary and pharmaceutical purposes, namely, for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination and immunostimmulation; disinfectants; plasters for medical purposes; materials for dressings, namely, medical, sterilized and surgical dressings; fungicides, herbicides | ACTIVE | — |
| 042 | Scientific and technological services, namely scientific research, scientific consultancy, technological consultancy and design in the field of biological, biomedical, medical, chemical and pharmaceutical research and development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LICIT Solutions GmbH
- Other trademarks owned by LICIT Solutions GmbH
- Other trademarks owned by LICIT Solutions GmbH
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named LICIT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 30, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 6, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 20, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 19, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 30, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 30, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 12, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 12, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 6, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 13, 2026 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Apr 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 9, 2026 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Apr 9, 2026 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Apr 9, 2026 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Apr 6, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 6, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 6, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 9, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 9, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 9, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 27, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 27, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 27, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 27, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 27, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 27, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 27, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 27, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 10, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 17, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 17, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 11, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 11, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 10, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 21, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 21, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 20, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |